Adaptive Biotechnologies: 3Q Earnings Snapshot
SEATTLE (AP) _ Adaptive Biotechnologies Corp. (ADPT) on Tuesday reported a loss of $14 million in its third quarter.
On a per-share basis, the Seattle-based company said it had a loss of 11 cents.
The life-sciences research company posted revenue of $26.1 million in the period, surpassing Street forecasts. Three analysts surveyed by Zacks expected $21.9 million.